Invasive Aspergillosis

Showing 1 - 25 of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Azole Resistance Inducing Mutations on DNA Extracted Directly

Recruiting
  • Invasive Aspergillosis
  • Aspergillus PCR
  • Rotterdam, Zuid Holland, Netherlands
    Erasmus Medical Center (EMC)
Oct 5, 2023

Invasive Aspergillosis Trial (Record the information data)

Not yet recruiting
  • Invasive Aspergillosis
  • Record the information data
  • (no location specified)
Aug 31, 2023

Invasive Candidiasis, Invasive Aspergillosis Trial in Tianjin (Amphotericin B cholesteryl Sulfate Complex for Injection)

Not yet recruiting
  • Invasive Candidiasis
  • Invasive Aspergillosis
  • Amphotericin B cholesteryl Sulfate Complex for Injection
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jan 29, 2023

Invasive Mucormycosis, Invasive Aspergillosis Trial in Worldwide (Isavuconazonium sulfate)

Completed
  • Invasive Mucormycosis
  • Invasive Aspergillosis
  • Isavuconazonium sulfate
  • Los Angeles, California
  • +9 more
Jan 13, 2023

Invasive Aspergillosis Trial in Pathum Wan (Olorofim, AmBisome®)

Recruiting
  • Invasive Aspergillosis
  • Sacramento, California
  • +44 more
Dec 16, 2022

Invasive Aspergillosis Trial in Belgium, Netherlands (Azole, Anidulafungin)

Recruiting
  • Invasive Aspergillosis
  • Ghent, Belgium
  • +3 more
Oct 1, 2021

Cerebral Aspergillosis Treated With Isavuconazole

Recruiting
  • Cerebral Aspergillosis
  • Invasive Aspergillosis
    • Paris, France
      Hôpital Necker-Enfants Malades
    Sep 6, 2021

    Patterns of Real-World Isavuconazole Use -Study of Mucormycosis

    Recruiting
    • Invasive Aspergillosis
    • Mucormycosis
    • Barcelona, Spain
      Fundació Clínic Per A La Recerca Biomèdica
    Jun 14, 2021

    Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell

    Unknown status
    • Invasive Aspergillosis
      • Berlin, Germany
      • +7 more
      Jan 13, 2021

      Diagnosing Pulmonary Aspergillosis in Hematological

      Completed
      • Invasive Aspergillosis
        • Innsbruck, Austria
        • +8 more
        Apr 17, 2020

        Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of

        Unknown status
        • Invasive Aspergillosis
        • +3 more
          • Mannheim, Germany
            University Hospital Mannheim
          Apr 17, 2020

          BAL of ICU Patients With Lung Infiltrates

          Unknown status
          • INvasive Aspergillosis
          • +4 more
            • Mannheim, Germany
              Mannheim University Hospital
            Apr 17, 2020

            Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction

            Completed
            • Invasive Aspergillosis
              • Innsbruck, Austria
              • +21 more
              Apr 17, 2020

              Pleural Effusion Aspergillosis Biomarker Testing

              Unknown status
              • Invasive Aspergillosis
              • +2 more
                • Mannheim, Baden-Wuerrtemberg, Germany
                • +1 more
                Apr 17, 2020

                Invasive Aspergillosis Trial in Nottingham (IV F901318, Oral F901318)

                Withdrawn
                • Invasive Aspergillosis
                • IV F901318
                • Oral F901318
                • Nottingham, Nottinghamshire, United Kingdom
                  Quotient Clinical
                Jul 24, 2019

                Invasive Aspergillosis, Invasive Pulmonary Aspergillosis Trial in Worldwide (Investigational Agent: VL-2397, Standard treatment:

                Terminated
                • Invasive Aspergillosis
                • Invasive Pulmonary Aspergillosis
                • Investigational Agent: VL-2397
                • Standard treatment: Voriconazole, Isavuconazole, or Liposomal amphotericin B
                • Birmingham, Alabama
                • +27 more
                Feb 25, 2019

                Combined Pharmacogenetic Score on Through Plasma Voriconazole

                Completed
                • Invasive Aspergillosis
                • +2 more
                  • Grenoble, France
                    University Hospital, Grenoble Alpes
                  Feb 15, 2019

                  Invasive Aspergillosis Trial in China (Micafungin)

                  Terminated
                  • Invasive Aspergillosis
                  • Beijing, China
                  • +18 more
                  Dec 18, 2018

                  Invasive Aspergillosis Trial in Cologne, Nijmegen (Registry)

                  Unknown status
                  • Invasive Aspergillosis
                  • Registry
                  • Cologne, NRW, Germany
                  • +1 more
                  Oct 29, 2018

                  Invasive Aspergillosis Trial in Leeds (F901318)

                  Completed
                  • Invasive Aspergillosis
                  • Leeds, West Yorkshire, United Kingdom
                    Covance Clinical Research Unit
                  Jul 31, 2018

                  Exhaled Breath Analysis in the Early Detection of Aspergillosis

                  Completed
                  • Invasive Aspergillosis
                    • Amsterdam, Netherlands
                    • +1 more
                    Jul 1, 2018

                    Invasive Aspergillosis Trial (F901318)

                    Withdrawn
                    • Invasive Aspergillosis
                    • (no location specified)
                    Oct 30, 2017

                    Invasive Aspergillosis Trial (cyclosporine A, Posaconazole, Pantoprazole)

                    Withdrawn
                    • Invasive Aspergillosis
                    • cyclosporine A
                    • +4 more
                    • (no location specified)
                    Oct 30, 2017

                    Invasive Aspergillosis Trial in Worldwide (Voriconazole)

                    Terminated
                    • Invasive Aspergillosis
                    • Los Angeles, California
                    • +24 more
                    May 23, 2017

                    Invasive Aspergillosis Trial in Merthyr Tydfil (F901318 Dose level A oral, Placebo dose level A oral, F901318 Dose level B oral)

                    Completed
                    • Invasive Aspergillosis
                    • F901318 Dose level A oral
                    • +5 more
                    • Merthyr Tydfil, Glamorgan, United Kingdom
                      Simbec Research Ltd
                    May 22, 2017